The impact of past COVID-19 infection on pregnancy rates in frozen embryo transfer cycles

• Published in: Journal of assisted reproduction and genetics 2022-07, Vol.39 (7), p.1565-1570
• Main Authors: Youngster, Michal, Avraham, Sarit, Yaakov, Odelia, Landau Rabbi, Moran, Gat, Itai, Yerushalmi, Gil, Baum, Micha, Maman, Ettie, Hourvitz, Ariel, Kedem, Alon
• Format: Article
• Language: English
• Subjects: Assisted Reproduction Technologies; Coronaviruses; COVID-19; Embryo transfer; Embryos; Gynecology; Human Genetics; Infections; Medicine; Medicine & Public Health; Oocytes; Patients; Pregnancy; Reproductive Medicine; Severe acute respiratory syndrome coronavirus 2
• ISSN: 1058-0468; 1573-7330
• DOI: 10.1007/s10815-022-02517-w

Purpose To study the effect of SARS-CoV-2 infection on pregnancy rates in frozen embryo transfer (FET) cycles. Methods A retrospective cohort study including women under the age of 42 with documented SARS-CoV-2 infection up to 1 year prior to treatment, undergoing FET cycles in the first half of 2021, with transfer of embryos generated prior to the infection. Controls were SARS-CoV-2 non-diagnosed, non-vaccinated women matched by age, number, and day of embryo transfer. Demographic and cycle characteristics and outcomes were compared. Results Forty-one recovered women and 41 controls were included. Pregnancy rates were 29% and 49% respectively ( p  = 0.070). Stratification by time from SARS-CoV-2 infection to transfer into ≤ 60 and > 60 days revealed a difference in pregnancy rates, with women in the COVID group having lower pregnancy rates if infected in proximity to the transfer (21% vs. 55%; p  = 0.006). In a logistic regression model, infection was a significant variable ( p  = 0.05, OR 0.325, 95% CI 0.106–0.998). Logistic regression applied on the subgroup of women infected in proximity to the transfer further strengthened the univariate results, with COVID-19 remaining a significant parameter ( p  = 0.005, OR 0.072, 95% CI 0.012–0.450). Conclusions In FET cycles of patients with past SARS-CoV-2 infection, in which oocytes were retrieved prior to infection, decreased pregnancy rates were observed, specifically in patients who recovered less than 60 days prior to embryo transfer. Pending further studies, in cases of FET cycles with limited number of embryos, postponing embryo transfer for at least 60 days following recovery from COVID-19 might be considered when feasible.